G. Muralidharan

543 total citations
9 papers, 443 citations indexed

About

G. Muralidharan is a scholar working on Pharmacology, Pharmacology and Molecular Medicine. According to data from OpenAlex, G. Muralidharan has authored 9 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 3 papers in Pharmacology and 3 papers in Molecular Medicine. Recurrent topics in G. Muralidharan's work include Pharmacogenetics and Drug Metabolism (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Antibiotic Resistance in Bacteria (3 papers). G. Muralidharan is often cited by papers focused on Pharmacogenetics and Drug Metabolism (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Antibiotic Resistance in Bacteria (3 papers). G. Muralidharan collaborates with scholars based in Canada and United States. G. Muralidharan's co-authors include Donald G. Raible, Steven Troy, Marlynne Micalizzi, John Speth, Richard J. Fruncillo, K.K. Midha, E. M. Hawes, G. McKay, E. D. Korchinski and Kyle Matschke and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Clinical Pharmacology & Therapeutics and European Journal of Clinical Pharmacology.

In The Last Decade

G. Muralidharan

9 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G. Muralidharan Canada	7	251	251	92	77	60	9	443
ISAMU SAIKAWA Japan	11	309 1.2×	228 0.9×	73 0.8×	74 1.0×	28 0.5×	87	618
Dawn Harper United States	8	115 0.5×	113 0.5×	44 0.5×	78 1.0×	23 0.4×	9	375
C A Knupp United States	13	308 1.2×	213 0.8×	150 1.6×	128 1.7×	61 1.0×	19	527
Zahra Sahraei Iran	6	109 0.4×	145 0.6×	72 0.8×	159 2.1×	36 0.6×	19	523
Henri Merdjan France	12	261 1.0×	206 0.8×	129 1.4×	33 0.4×	59 1.0×	22	441
Christophe Padoin France	13	236 0.9×	83 0.3×	123 1.3×	103 1.3×	29 0.5×	21	439
Rajbharan Yadav United States	16	243 1.0×	276 1.1×	118 1.3×	20 0.3×	78 1.3×	29	567
Brenda Cirincione United States	17	508 2.0×	310 1.2×	160 1.7×	124 1.6×	103 1.7×	32	1.1k
Gurudatt Chandorkar United States	12	228 0.9×	199 0.8×	185 2.0×	109 1.4×	48 0.8×	14	498
Xiaojie Wu China	17	382 1.5×	227 0.9×	294 3.2×	137 1.8×	33 0.6×	71	818

Countries citing papers authored by G. Muralidharan

Since Specialization

Citations

This map shows the geographic impact of G. Muralidharan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Muralidharan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Muralidharan more than expected).

Fields of papers citing papers by G. Muralidharan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Muralidharan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Muralidharan. The network helps show where G. Muralidharan may publish in the future.

Co-authorship network of co-authors of G. Muralidharan

This figure shows the co-authorship network connecting the top 25 collaborators of G. Muralidharan. A scholar is included among the top collaborators of G. Muralidharan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Muralidharan. G. Muralidharan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Muralidharan, G., et al.. (2014). FORMULATION AND EVALUATION OF ORODISPERSIBLE TABLETS OF ZOLMITRIPTAN. Asian Journal of Pharmaceutical and Clinical Research. 7(6). 127–134. 4 indexed citations

Korth‐Bradley, Joan, Steven Troy, Kyle Matschke, et al.. (2011). Tigecycline Pharmacokinetics in Subjects With Various Degrees of Renal Function. The Journal of Clinical Pharmacology. 52(9). 1379–1387. 34 indexed citations

Muralidharan, G., Richard J. Fruncillo, Marlynne Micalizzi, Donald G. Raible, & Steven Troy. (2005). Effects of Age and Sex on Single-Dose Pharmacokinetics of Tigecycline in Healthy Subjects. Antimicrobial Agents and Chemotherapy. 49(4). 1656–1659. 52 indexed citations

Muralidharan, G., Marlynne Micalizzi, John Speth, Donald G. Raible, & Steven Troy. (2004). Pharmacokinetics of Tigecycline after Single and Multiple Doses in Healthy Subjects. Antimicrobial Agents and Chemotherapy. 49(1). 220–229. 280 indexed citations

Muralidharan, G., et al.. (1999). Pharmacokinetics and pharmacodynamics of a novel vasopressin receptor antagonist, VPA-985, in healthy subjects. Clinical Pharmacology & Therapeutics. 65(2). 189–189. 6 indexed citations

Muralidharan, G., J.K. Cooper, E. M. Hawes, E. D. Korchinski, & K.K. Midha. (1996). Quinidine inhibits the 7-hydroxylation of chlorpromazine in extensive metabolisers of debrisoquine. European Journal of Clinical Pharmacology. 50(1-2). 121–128. 21 indexed citations

Muralidharan, G., E. M. Hawes, G. McKay, & K.K. Midha. (1991). Quinine is a more potent inhibitor than quinidine in rat of the oxidative metabolic routes of methoxyphenamine which involve debrisoquine 4-hydroxylase. Xenobiotica. 21(11). 1441–1450. 11 indexed citations

Muralidharan, G., E. M. Hawes, G. McKay, E. D. Korchinski, & K.K. Midha. (1991). Quinidine but not quinine inhibits in man the oxidative metabolic routes of methoxyphenamine which involve debrisoquine 4-hydroxylase. European Journal of Clinical Pharmacology. 41(5). 471–474. 24 indexed citations

Muralidharan, G., K.K. Midha, G. McKay, E. M. Hawes, & T. Inaba. (1989). Selectivein vivoinhibition by quinidine of methoxyphenamine oxidation in rat models of human debrisoquine polymorphism. Xenobiotica. 19(2). 189–197. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact